Results 231 to 240 of about 1,284,058 (379)
THE CONTENT OF CFLIPL IN THE CELL DETERMINES THE PREFERENTIAL PATHWAY OF PROGRAMMED CELL DEATH
Т. О. Волкова, A. Poltorak
openalex +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
Metal-Based Nanomedicines for Inducing Programmed Cell Death to Enhance the Efficacy of Cancer Immunotherapy. [PDF]
Cheng X, Park N, Lee Y.
europepmc +1 more source
Cognitive Behavioral Therapy for Youth with Childhood‐Onset Lupus: A Randomized Clinical Trial
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham +29 more
wiley +1 more source
A computational analysis of programmed cell death-associated LncRNA signatures in glioma and drug prediction. [PDF]
Liu X +5 more
europepmc +1 more source
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
Ouyang Liang +7 more
semanticscholar +1 more source
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang +9 more
wiley +1 more source

